During the last session, ClearPoint Neuro Inc. (NASDAQ:CLPT)’s traded shares were 0.12 million, with the beta value of the company hitting 1.11. At the end of the trading day, the stock’s price was $15.57, reflecting an intraday gain of 1.04% or $0.16. The 52-week high for the CLPT share is $22.80, that puts it down -46.44 from that peak though still a striking 55.04% gain since the share price plummeted to a 52-week low of $7.00. The company’s market capitalization is $366.67M, and the average intraday trading volume over the past 10 days was 0.1 million shares, and the average trade volume was 214.62K shares over the past three months.
ClearPoint Neuro Inc. (CLPT) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 2.00. CLPT has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.18.
ClearPoint Neuro Inc. (NASDAQ:CLPT) trade information
ClearPoint Neuro Inc. (CLPT) registered a 1.04% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.04% in intraday trading to $15.57 this Friday, 08/05/22, hitting a weekly high. The stock’s 5-day price performance is 9.88%, and it has moved by 10.66% in 30 days. Based on these gigs, the overall price performance for the year is -29.03%. The short interest in ClearPoint Neuro Inc. (NASDAQ:CLPT) is 1.29 million shares and it means that shorts have 4.65 day(s) to cover.
The consensus price target of analysts on Wall Street is $18.50, which implies an increase of 15.84% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $15.00 and $22.00 respectively. As a result, CLPT is trading at a discount of -41.3% off the target high and 3.66% off the low.
ClearPoint Neuro Inc. (CLPT) estimates and forecasts
Statistics show that ClearPoint Neuro Inc. has underperformed its competitors in share price, compared to the industry in which it operates. ClearPoint Neuro Inc. (CLPT) shares have gone up 87.36% during the last six months, with a year-to-date growth rate less than the industry average at -4.35% against 2.60. In the rating firms’ projections, revenue will increase 29.90% compared to the previous financial year.
Revenue for the current quarter is expected to be $5.08 million as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to $5.4 million by the end of Sep 2022. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $3.41 million and $4.57 million respectively. In this case, analysts expect current quarter sales to grow by 48.80% and then jump by 18.10% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 25.00%. While earnings are projected to return -62.40% in 2022, the next five years will return 30.00% per annum.
ClearPoint Neuro Inc. is due to release its next quarterly earnings between March 02 and March 07. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
ClearPoint Neuro Inc. (NASDAQ:CLPT)’s Major holders
ClearPoint Neuro Inc. insiders own 13.31% of total outstanding shares while institutional holders control 23.53%, with the float percentage being 27.15%. Blackrock Inc. is the largest shareholder of the company, while 99 institutions own stock in it. As of Mar 30, 2022, the company held over 1.17 million shares (or 4.93% of all shares), a total value of $12.18 million in shares.
The next largest institutional holding, with 1.08 million shares, is of Vanguard Group, Inc. (The)’s that is approximately 4.56% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $11.25 million.
Also, the Mutual Funds coming in first place with the largest holdings of ClearPoint Neuro Inc. (CLPT) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Mar 30, 2022 indicates that Vanguard Total Stock Market Index Fund owns about 0.7 million shares. This amounts to just over 2.96 percent of the company’s overall shares, with a $7.29 million market value. The same data shows that the other fund manager holds slightly less at 0.25 million, or about 1.07% of the stock, which is worth about $2.63 million.